Compare Stocks

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARTL Artelo Biosciences	$1.28 -2.3%	$1.52	$1.15 ▼ $2.98	$4.13M	1.45	16,233 shs	14,179 shs
ERF Enerplus	$19.83 -1.1%	$18.44	$13.46 ▼ $20.97	$4.05B	1.99	3.04 million shs	1.82 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARTL Artelo Biosciences	-2.66%	-18.94%	-14.67%	-10.49%	-53.17%
ERF Enerplus	-1.10%	-4.02%	+5.37%	+43.33%	+34.99%

Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARTL Artelo Biosciences	2.1497 of 5 stars	3.5	5.0	0.0	0.0	0.6	0.0	1.3
ERF Enerplus	2.7626 of 5 stars	1.5	5.0	2.5	0.0	2.6	0.8	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARTL Artelo Biosciences	3.00	Buy	$5.00	290.63% Upside
ERF Enerplus	3.00	Buy	$21.69	9.39% Upside

Current Analyst Ratings

Latest UAI, ERF, ARTL, AFA, and EGH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/2/2024	ARTL Artelo Biosciences	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
2/22/2024	ERF Enerplus	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Tender	$21.00 ➝ $18.85

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARTL Artelo Biosciences	N/A	N/A	N/A	N/A	$4.12 per share	N/A
ERF Enerplus	$1.69B	2.39	$4.12 per share	4.81	$6.07 per share	3.27

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARTL Artelo Biosciences	-$9.29M	-$3.14	N/A	N/A	N/A	N/A	-61.68%	-58.15%	5/9/2024 (Estimated)
ERF Enerplus	$456.08M	$2.10	9.44	8.40	N/A	27.67%	40.36%	23.44%	5/2/2024 (Estimated)

Latest UAI, ERF, ARTL, AFA, and EGH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/21/2024	Q4 2023	ERF Enerplus	$0.53	$0.54	+$0.01	$0.53	N/A	$437.10 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARTL Artelo Biosciences	N/A	N/A	N/A	N/A	N/A
ERF Enerplus	$0.26	1.31%	+37.49%	12.38%	4 Years

Latest UAI, ERF, ARTL, AFA, and EGH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/21/2024	ERF Enerplus	Quarterly	$0.13	2.9%	3/1/2024	3/4/2024	3/15/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARTL Artelo Biosciences	N/A	8.51	8.51
ERF Enerplus	0.09	0.80	0.80

Ownership

Institutional Ownership

Company	Institutional Ownership
ARTL Artelo Biosciences	0.87%
ERF Enerplus	58.42%

Insider Ownership

Company	Insider Ownership
ARTL Artelo Biosciences	6.90%
ERF Enerplus	0.41%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ARTL Artelo Biosciences	5	3.23 million	3.01 million	Not Optionable
ERF Enerplus	404	204.25 million	203.41 million	Optionable

ERF, UAI, FOXT, PURP, and ARTL Headlines

Source	Headline
	ENERPLUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enerplus Corporation - ERF businesswire.com - April 15 at 4:02 PM
	Trican Well Service (TOLWF) Receives a Rating Update from a Top Analyst markets.businessinsider.com - April 14 at 9:36 AM
	Enerplus Co. (NYSE:ERF) Shares Purchased by Allspring Global Investments Holdings LLC marketbeat.com - April 14 at 5:36 AM
	Enerplus (NYSE:ERF) Coverage Initiated by Analysts at StockNews.com americanbankingnews.com - April 14 at 2:16 AM
	Enerplus (NYSE:ERF) Coverage Initiated at StockNews.com marketbeat.com - April 14 at 2:15 AM
	Tobam Lowers Stock Holdings in Enerplus Co. (NYSE:ERF) marketbeat.com - April 12 at 6:28 AM
	Enerplus Co. (NYSE:ERF) Receives Average Rating of "Buy" from Brokerages americanbankingnews.com - April 12 at 3:08 AM
	Enerplus Co. (NYSE:ERF) Receives Consensus Rating of "Buy" from Analysts marketbeat.com - April 12 at 2:33 AM
	Enerplus (ERF) Is Up 3.51% in One Week: What You Should Know zacks.com - April 9 at 1:01 PM
	Enerplus (NYSE:ERF) Reaches New 52-Week High at $20.52 marketbeat.com - April 8 at 10:46 AM
	Chord Energy and Enerplus Announce Expiration of Hart-Scott-Rodino Act Waiting Period and Provide Transaction Update prnewswire.com - April 8 at 6:00 AM
	FY2024 Earnings Forecast for Enerplus Co. (NYSE:ERF) Issued By Capital One Financial marketbeat.com - April 5 at 8:36 AM
	Vanguard Group Inc. Sells 131,825 Shares of Enerplus Co. (NYSE:ERF) marketbeat.com - April 3 at 4:09 AM
	Enerplus (NYSE:ERF) Reaches New 1-Year High at $19.85 marketbeat.com - April 2 at 10:47 AM
	Enerplus Co. (NYSE:ERF) Short Interest Update marketbeat.com - March 31 at 12:19 AM
	StockNews.com Begins Coverage on Enerplus (NYSE:ERF) marketbeat.com - March 29 at 2:12 AM
	Enerplus (NYSE:ERF) Hits New 12-Month High at $19.23 marketbeat.com - March 27 at 11:24 AM
	Klein Pavlis & Peasley Financial Inc. Takes $1.55 Million Position in Enerplus Co. (NYSE:ERF) marketbeat.com - March 24 at 7:26 AM
	Enerplus Co. (NYSE:ERF) Shares Purchased by American Century Companies Inc. marketbeat.com - March 22 at 4:17 AM
	6 Undervalued Oil & Gas - Exploration and Production Stocks for Wednesday, March 13 aaii.com - March 13 at 11:57 AM
	Ex-Dividend Reminder: LyondellBasell Industries, Suncor Energy and Enerplus nasdaq.com - March 1 at 12:33 PM
	ENERPLUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enerplus Corporation - ERF businesswire.com - February 26 at 11:40 AM
	Chord Energy and Enerplus Announce $11 Billion Merger Agreement thedeepdive.ca - February 23 at 5:15 PM
	Shareholder Alert: Ademi LLP investigates whether Enerplus Corporation has obtained a Fair Price in its transaction with Chord prnewswire.com - February 22 at 1:46 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Breakout Alert: Coinbase's Consolidation Is About To End
April 12, 2024 9:45 AM
View Breakout Alert: Coinbase's Consolidation Is About To End
Mid-Cap Stocks to Outperform the Market This Cycle
March 27, 2024 9:45 AM
View Mid-Cap Stocks to Outperform the Market This Cycle
Does Reddit's Successful Public Debut Mean Tech IPOs are Back?
March 22, 2024 6:15 AM
View Does Reddit's Successful Public Debut Mean Tech IPOs are Back?
McCormick & Company Stock Isn’t Cheap, But It Is Undervalued
March 26, 2024 10:28 AM
View McCormick & Company Stock Isn’t Cheap, But It Is Undervalued
How to Use an Options Call Butterfly for Rangebound Stocks
April 4, 2024 7:57 AM
View How to Use an Options Call Butterfly for Rangebound Stocks

All Headlines

Company Descriptions

Artelo Biosciences

NASDAQ:ARTL

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Enerplus

NYSE:ERF

Enerplus Corporation, together with its subsidiaries, explores and develops crude oil and natural gas in the United States. Its oil and natural gas properties are located primarily in North Dakota, Colorado, and Pennsylvania. The company was founded in 1986 and is headquartered in Calgary, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial